06114133 is referenced by 87 patents and cites 19 patents.

This invention provides methods useful in aiding in the diagnosis of Alzheimer's disease. The methods involve measuring the amount of amyloid-.beta. peptide (x-.gtoreq.41) in the cerebrospinal fluid of a patient. High levels of the peptide generally are inconsistent with a diagnosis of Alzheimer's. Low levels of the peptide are consistent with the disease and, with other tests, can provide a positive diagnosis.

Title
Methods for aiding in the diagnosis of Alzheimers disease by measuring amyloid-.beta. peptide (x-.gtoreq.41)
Application Number
8/339141
Publication Number
6114133
Application Date
November 14, 1994
Publication Date
September 5, 2000
Inventor
Robin Barbour
Newark
CA, US
Dale B Schenk
Pacifica
CA, US
Carmen Vigo Pelfrey
Mountain View
CA, US
Peter A Seubert
South San Francisco
CA, US
Agent
Jean M Duvall
Carol A Stratford
Assignee
Eli Lilly & Company
IN, US
Elan Pharmaceuticals
CA, US
IPC
G01N 33/53
View Original Source